{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:16:38Z","timestamp":1792545398757,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100015763","name":"University of Szeged","doi-asserted-by":"crossref","award":["EFOP-3.6.3-VEKOP-16-2017-00009"],"award-info":[{"award-number":["EFOP-3.6.3-VEKOP-16-2017-00009"]}],"id":[{"id":"10.13039\/501100015763","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100015763","name":"University of Szeged","doi-asserted-by":"crossref","award":["Open Access Fund Grant 6680"],"award-info":[{"award-number":["Open Access Fund Grant 6680"]}],"id":[{"id":"10.13039\/501100015763","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt Foundation","doi-asserted-by":"crossref","award":["Research Group Linkage Program between the Institutes of Physiology of the FAU Erlangen-N\u00fcrnberg and the University of Szeged"],"award-info":[{"award-number":["Research Group Linkage Program between the Institutes of Physiology of the FAU Erlangen-N\u00fcrnberg and the University of Szeged"]}],"id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt Foundation","doi-asserted-by":"crossref","award":["Research Group Linkage Program between the Institutes of Physiology of the FAU Erlangen-N\u00fcrnberg and the University of Szeged"],"award-info":[{"award-number":["Research Group Linkage Program between the Institutes of Physiology of the FAU Erlangen-N\u00fcrnberg and the University of Szeged"]}],"id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hungarian National Research, Development and Innovation Office","award":["K119597"],"award-info":[{"award-number":["K119597"]}]},{"DOI":"10.13039\/501100015763","name":"University of Szeged","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015763","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Monoclonal antibodies directed against the neuropeptide calcitonin gene-related peptide (CGRP) are effective in the prevention of chronic and frequent episodic migraine. Since the antibodies do not cross the blood brain barrier, their antinociceptive effect is attributed to effects in meningeal tissues. We aimed to probe if such an antibody can be visualized within the dura mater and the trigeminal ganglia following its administration to rats and to examine if the activity of the trigeminovascular nocisensor complex is influenced by this treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Effects of the anti-CGRP antibody galcanezumab on the trigeminovascular nocisensor complex was examined by measuring release of sensory neuropeptides and histamine from the rat dura mater. Deposits of galcanezumab were visualized by fluorescence microscopy in the trigeminal ganglion and the dura mater.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fluorophore-labelled galcanezumab was detected in the dura mater and the trigeminal ganglion up to 30\u00a0days after treatment affirming the long-lasting modulatory effect of this antibody. In female rats, seven days after systemic treatment with galcanezumab the capsaicin-induced release of CGRP was decreased, while that of substance P (SP) was increased in the dura mater. In control rats, release of the inhibitory neuropeptide somatostatin (SOM) was higher in females than in males. Stimulation with high concentration of KCl did not significantly change the release of SOM in control animals, while in rats treated with galcanezumab SOM release was slightly reduced. Galcanezumab treatment also reduced the amount of histamine released from dural mast cells upon stimulation with CGRP, while the effect of compound 48\/80 on histamine release was not changed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Galcanezumab treatment is followed by multiple changes in the release of neuropeptides and histamine in the trigeminal nocisensor complex, which may contribute to the migraine preventing effect of anti-CGRP antibodies. These changes affecting the communication between the components of the trigeminal nocisensor complex may reduce pain susceptibility in migraine patients treated with CGRP targeting monoclonal antibodies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10194-024-01717-2","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T08:02:17Z","timestamp":1705651337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Anti-CGRP antibody galcanezumab modifies the function of the trigeminovascular nocisensor complex in the rat"],"prefix":"10.1186","volume":"25","author":[{"given":"Nadine","family":"Friedrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Rosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildik\u00f3","family":"Dobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orsolya","family":"Oszl\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Jancs\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Messlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ria","family":"Dux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,19]]},"reference":[{"key":"1717_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00424-012-1142-7","volume":"464","author":"M Dux","year":"2012","unstructured":"Dux M, S\u00e1ntha P, Jancs\u00f3 G (2012) The role of chemosensitive afferent nerves and TRP ion channels in the pathomechanism of headaches. Pflugers Arch 464:239\u2013248. https:\/\/doi.org\/10.1007\/s00424-012-1142-7","journal-title":"Pflugers Arch"},{"key":"1717_CR2","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.jpain.2013.03.010","volume":"14","author":"S Eftekhari","year":"2013","unstructured":"Eftekhari S, Warfvinge K, Blixt FW, Edvinsson L (2013) Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system. J Pain 14:1289\u20131303. https:\/\/doi.org\/10.1016\/j.jpain.2013.03.010","journal-title":"J Pain"},{"key":"1717_CR3","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/cne.21607","volume":"507","author":"JK Lennerz","year":"2008","unstructured":"Lennerz JK, R\u00fchle V, Ceppa EP et al (2008) Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 507:1277\u20131299. https:\/\/doi.org\/10.1002\/cne.21607","journal-title":"J Comp Neurol"},{"issue":"Suppl 1","key":"1717_CR4","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/j.pain.2013.07.021","volume":"154","author":"R Noseda","year":"2013","unstructured":"Noseda R, Burstein R (2013) Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain. Pain 154(Suppl 1):S44-53. https:\/\/doi.org\/10.1016\/j.pain.2013.07.021","journal-title":"Pain"},{"key":"1717_CR5","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1152\/jn.1998.79.2.964","volume":"79","author":"R Burstein","year":"1998","unstructured":"Burstein R, Yamamura H, Malick A, Strassman AM (1998) Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79:964\u2013982. https:\/\/doi.org\/10.1152\/jn.1998.79.2.964","journal-title":"J Neurophysiol"},{"key":"1717_CR6","first-page":"15","volume":"11","author":"J Tajti","year":"2009","unstructured":"Tajti J, V\u00e9csei L (2009) The mechanism of peripheral and central sensitization in migraine. A literature review. Neuropsychopharmacol Hung 11:15\u201321","journal-title":"Neuropsychopharmacol Hung"},{"key":"1717_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/ijms21010342","volume":"21","author":"M Dux","year":"2020","unstructured":"Dux M, Rosta J, Messlinger K (2020) TRP channels in the focus of trigeminal nociceptor sensitization contributing to primary headaches. Int J Mol Sci 21:342. https:\/\/doi.org\/10.3390\/ijms21010342","journal-title":"Int J Mol Sci"},{"key":"1717_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1744-8069-8-66","volume":"8","author":"D Huang","year":"2012","unstructured":"Huang D, Li S, Dhaka A et al (2012) Expression of the transient receptor potential channels TRPV1, TRPA1 and TRPM8 in mouse trigeminal primary afferent neurons innervating the dura. Mol Pain 8:66. https:\/\/doi.org\/10.1186\/1744-8069-8-66","journal-title":"Mol Pain"},{"key":"1717_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.npep.2015.03.006","volume":"52","author":"J Tajti","year":"2015","unstructured":"Tajti J, Szok D, Majl\u00e1th Z et al (2015) Migraine and neuropeptides. Neuropeptides 52:19\u201330. https:\/\/doi.org\/10.1016\/j.npep.2015.03.006","journal-title":"Neuropeptides"},{"key":"1717_CR10","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/head.13529","volume":"59","author":"S Iyengar","year":"2019","unstructured":"Iyengar S, Johnson KW, Ossipov MH, Aurora SK (2019) CGRP and the trigeminal system in migraine. Headache 59:659\u2013681. https:\/\/doi.org\/10.1111\/head.13529","journal-title":"Headache"},{"key":"1717_CR11","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1007\/s00415-023-11706-1","volume":"270","author":"F Puledda","year":"2023","unstructured":"Puledda F, Silva EM, Suwanlaong K, Goadsby PJ (2023) Migraine: from pathophysiology to treatment. J Neurol 270:3654\u20133666. https:\/\/doi.org\/10.1007\/s00415-023-11706-1","journal-title":"J Neurol"},{"key":"1717_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s40120-021-00250-7","volume":"10","author":"A Blumenfeld","year":"2021","unstructured":"Blumenfeld A, Durham PL, Feoktistov A et al (2021) Hypervigilance, allostatic load, and migraine prevention: antibodies to CGRP or receptor. Neurol Ther 10:469\u2013497. https:\/\/doi.org\/10.1007\/s40120-021-00250-7","journal-title":"Neurol Ther"},{"key":"1717_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neuropharm.2019.02.015","volume":"149","author":"N Mikhailov","year":"2019","unstructured":"Mikhailov N, Leskinen J, Fagerlund I et al (2019) Mechanosensitive meningeal nociception via Piezo channels: implications for pulsatile pain in migraine? Neuropharmacology 149:113\u2013123. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.02.015","journal-title":"Neuropharmacology"},{"key":"1717_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0891-0618(94)90027-2","volume":"7","author":"M Del Fiacco","year":"1994","unstructured":"Del Fiacco M, Quartu M (1994) Somatostatin, galanin and peptide histidine isoleucine in the newborn and adult human trigeminal ganglion and spinal nucleus: immunohistochemistry, neuronal morphometry and colocalization with substance P. J Chem Neuroanat 7:171\u2013184. https:\/\/doi.org\/10.1016\/0891-0618(94)90027-2","journal-title":"J Chem Neuroanat"},{"key":"1717_CR15","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.neuroscience.2007.06.048","volume":"148","author":"M Takeda","year":"2007","unstructured":"Takeda M, Kadoi J, Takahashi M et al (2007) Somatostatin inhibits the excitability of rat small-diameter trigeminal ganglion neurons that innervate nasal mucosa and project to the upper cervical dorsal horn via activation of somatostatin 2a receptor. Neuroscience 148:744\u2013756. https:\/\/doi.org\/10.1016\/j.neuroscience.2007.06.048","journal-title":"Neuroscience"},{"key":"1717_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1468-2982.2005.01048.x","volume":"26","author":"P Sarchielli","year":"2006","unstructured":"Sarchielli P, Alberti A, Candeliere A et al (2006) Glial cell line-derived neurotrophic factor and somatostatin levels in cerebrospinal fluid of patients affected by chronic migraine and fibromyalgia. Cephalalgia 26:409\u2013415. https:\/\/doi.org\/10.1111\/j.1468-2982.2005.01048.x","journal-title":"Cephalalgia"},{"key":"1717_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0143-4179(92)90065-5","volume":"22","author":"L V\u00e9csei","year":"1992","unstructured":"V\u00e9csei L, Widerl\u00f6v E, Ekman R et al (1992) Suboccipital cerebrospinal fluid and plasma concentrations of somatostatin, neuropeptide Y and beta-endorphin in patients with common migraine. Neuropeptides 22:111\u2013116. https:\/\/doi.org\/10.1016\/0143-4179(92)90065-5","journal-title":"Neuropeptides"},{"key":"1717_CR18","doi-asserted-by":"publisher","first-page":"106072","DOI":"10.1016\/j.nbd.2023.106072","volume":"180","author":"L Biscetti","year":"2023","unstructured":"Biscetti L, Cresta E, Cupini LM et al (2023) The putative role of neuroinflammation in the complex pathophysiology of migraine: from bench to bedside. Neurobiol Dis 180:106072. https:\/\/doi.org\/10.1016\/j.nbd.2023.106072","journal-title":"Neurobiol Dis"},{"issue":"Suppl 1","key":"1717_CR19","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1111\/j.1526-4610.2006.00485.x","volume":"46","author":"D Levy","year":"2006","unstructured":"Levy D, Burstein R, Strassman AM (2006) Mast cell involvement in the pathophysiology of migraine headache: a hypothesis. Headache 46(Suppl 1):S13-18. https:\/\/doi.org\/10.1111\/j.1526-4610.2006.00485.x","journal-title":"Headache"},{"key":"1717_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0306-4522(91)90253-K","volume":"44","author":"V Dimitriadou","year":"1991","unstructured":"Dimitriadou V, Buzzi MG, Moskowitz MA, Theoharides TC (1991) Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells. Neuroscience 44:97\u2013112","journal-title":"Neuroscience"},{"key":"1717_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1046\/j.1468-2982.1997.1703166.x","volume":"17","author":"A Ottosson","year":"1997","unstructured":"Ottosson A, Edvinsson L (1997) Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide. Cephalalgia 17:166\u2013174. https:\/\/doi.org\/10.1046\/j.1468-2982.1997.1703166.x","journal-title":"Cephalalgia"},{"key":"1717_CR22","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/s13311-022-01230-x","volume":"19","author":"F Cohen","year":"2022","unstructured":"Cohen F, Yuan H, DePoy EMG, Silberstein SD (2022) The arrival of anti-CGRP monoclonal antibodies in migraine. Neurotherapeutics 19:922\u2013930. https:\/\/doi.org\/10.1007\/s13311-022-01230-x","journal-title":"Neurotherapeutics"},{"key":"1717_CR23","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s13311-018-0622-7","volume":"15","author":"B Raffaelli","year":"2018","unstructured":"Raffaelli B, Reuter U (2018) The biology of monoclonal antibodies: focus on calcitonin gene-related peptide for prophylactic migraine therapy. Neurotherapeutics 15:324\u2013335. https:\/\/doi.org\/10.1007\/s13311-018-0622-7","journal-title":"Neurotherapeutics"},{"key":"1717_CR24","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1177\/0333102419844711","volume":"39","author":"KW Johnson","year":"2019","unstructured":"Johnson KW, Morin SM, Wroblewski VJ, Johnson MP (2019) Peripheral and central nervous system distribution of the CGRP neutralizing antibody [125I] galcanezumab in male rats. Cephalalgia 39:1241\u20131248. https:\/\/doi.org\/10.1177\/0333102419844711","journal-title":"Cephalalgia"},{"key":"1717_CR25","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.3390\/cells11111768","volume":"11","author":"M Dux","year":"2022","unstructured":"Dux M, Vogler B, Kuhn A et al (2022) The anti-CGRP antibody fremanezumab lowers CGRP release from rat dura mater and meningeal blood flow. Cells 11:1768. https:\/\/doi.org\/10.3390\/cells11111768","journal-title":"Cells"},{"key":"1717_CR26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/BF01611735","volume":"15","author":"S Gulbenkian","year":"1986","unstructured":"Gulbenkian S, Merighi A, Wharton J et al (1986) Ultrastructural evidence for the coexistence of calcitonin gene-related peptide and substance P in secretory vesicles of peripheral nerves in the Guinea pig. J Neurocytol 15:535\u2013542. https:\/\/doi.org\/10.1007\/BF01611735","journal-title":"J Neurocytol"},{"key":"1717_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/0333102419896760","volume":"40","author":"R Noseda","year":"2020","unstructured":"Noseda R, Schain AJ, Melo-Carrillo A et al (2020) Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier. Cephalalgia 40:229\u2013240. https:\/\/doi.org\/10.1177\/0333102419896760","journal-title":"Cephalalgia"},{"key":"1717_CR28","doi-asserted-by":"publisher","first-page":"13471","DOI":"10.3390\/ijms241713471","volume":"24","author":"B Vogler","year":"2023","unstructured":"Vogler B, Kuhn A, Mackenzie KD et al (2023) The anti-calcitonin gene-related peptide (anti-CGRP) antibody fremanezumab reduces trigeminal neurons immunoreactive to CGRP and CGRP receptor components in rats. Int J Mol Sci 24:13471. https:\/\/doi.org\/10.3390\/ijms241713471","journal-title":"Int J Mol Sci"},{"key":"1717_CR29","doi-asserted-by":"publisher","first-page":"015006","DOI":"10.1088\/2050-6120\/abb363","volume":"9","author":"G T\u00f6r\u00f6k","year":"2021","unstructured":"T\u00f6r\u00f6k G, Cser\u00e9p GB, Telek A et al (2021) Large stokes-shift bioorthogonal probes for STED, 2P-STED and multi-color STED nanoscopy. Methods Appl Fluoresc 9:015006. https:\/\/doi.org\/10.1088\/2050-6120\/abb363","journal-title":"Methods Appl Fluoresc"},{"key":"1717_CR30","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S0306-4522(98)00366-2","volume":"89","author":"A Ebersberger","year":"1999","unstructured":"Ebersberger A, Averbeck B, Messlinger K, Reeh PW (1999) Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro. Neuroscience 89:901\u2013907","journal-title":"Neuroscience"},{"key":"1717_CR31","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1468-2982.2007.01321.x","volume":"27","author":"N Schwenger","year":"2007","unstructured":"Schwenger N, Dux M, de Col R et al (2007) Interaction of calcitonin gene-related peptide, nitric oxide and histamine release in neurogenic blood flow and afferent activation in the rat cranial dura mater. Cephalalgia 27:481\u2013491. https:\/\/doi.org\/10.1111\/j.1468-2982.2007.01321.x","journal-title":"Cephalalgia"},{"key":"1717_CR32","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.3390\/cells10102712","volume":"10","author":"JK Hennigs","year":"2021","unstructured":"Hennigs JK, Matuszcak C, Trepel M, K\u00f6rbelin J (2021) Vascular endothelial cells: heterogeneity and targeting approaches. Cells 10:2712. https:\/\/doi.org\/10.3390\/cells10102712","journal-title":"Cells"},{"key":"1717_CR33","doi-asserted-by":"publisher","first-page":"10623","DOI":"10.1073\/pnas.1434429100","volume":"100","author":"J-T Chi","year":"2003","unstructured":"Chi J-T, Chang HY, Haraldsen G et al (2003) Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci U S A 100:10623\u201310628. https:\/\/doi.org\/10.1073\/pnas.1434429100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1717_CR34","doi-asserted-by":"publisher","first-page":"e2211","DOI":"10.1212\/WNL.0000000000006640","volume":"91","author":"HC Detke","year":"2018","unstructured":"Detke HC, Goadsby PJ, Wang S et al (2018) Galcanezumab in chronic migraine: the randomized, double-blind, placebo-controlled REGAIN study. Neurology 91:e2211\u2013e2221. https:\/\/doi.org\/10.1212\/WNL.0000000000006640","journal-title":"Neurology"},{"key":"1717_CR35","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3389\/fphar.2017.00740","volume":"8","author":"D Monteith","year":"2017","unstructured":"Monteith D, Collins EC, Vandermeulen C et al (2017) Safety, tolerability, pharmacokinetics, and pharmacodynamics of the CGRP binding monoclonal antibody LY2951742 (galcanezumab) in healthy volunteers. Front Pharmacol 8:740. https:\/\/doi.org\/10.3389\/fphar.2017.00740","journal-title":"Front Pharmacol"},{"key":"1717_CR36","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/syn.890060406","volume":"6","author":"MB Plenderleith","year":"1990","unstructured":"Plenderleith MB, Haller CJ, Snow PJ (1990) Peptide coexistence in axon terminals within the superficial dorsal horn of the rat spinal cord. Synapse 6:344\u2013350. https:\/\/doi.org\/10.1002\/syn.890060406","journal-title":"Synapse"},{"key":"1717_CR37","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(19)30185-1","volume":"18","author":"M Ashina","year":"2019","unstructured":"Ashina M, Hansen JM, Do TP et al (2019) Migraine and the trigeminovascular system-40 years and counting. Lancet Neurol 18:795\u2013804. https:\/\/doi.org\/10.1016\/S1474-4422(19)30185-1","journal-title":"Lancet Neurol"},{"key":"1717_CR38","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1002\/art.20184","volume":"50","author":"Z Helyes","year":"2004","unstructured":"Helyes Z, Szab\u00f3 A, N\u00e9meth J et al (2004) Antiinflammatory and analgesic effects of somatostatin released from capsaicin-sensitive sensory nerve terminals in a Freund\u2019s adjuvant-induced chronic arthritis model in the rat. Arthritis Rheum 50:1677\u20131685. https:\/\/doi.org\/10.1002\/art.20184","journal-title":"Arthritis Rheum"},{"key":"1717_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0300-9629(89)90206-5","volume":"93","author":"MA Kai-Kai","year":"1989","unstructured":"Kai-Kai MA (1989) Cytochemistry of the trigeminal and dorsal root ganglia and spinal cord of the rat. Comp Biochem Physiol A Comp Physiol 93:183\u2013193. https:\/\/doi.org\/10.1016\/0300-9629(89)90206-5","journal-title":"Comp Biochem Physiol A Comp Physiol"},{"key":"1717_CR40","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/BF00218569","volume":"245","author":"W Kummer","year":"1986","unstructured":"Kummer W, Heym C (1986) Correlation of neuronal size and peptide immunoreactivity in the Guinea-pig trigeminal ganglion. Cell Tissue Res 245:657\u2013665. https:\/\/doi.org\/10.1007\/BF00218569","journal-title":"Cell Tissue Res"},{"key":"1717_CR41","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0065-1281(11)80323-5","volume":"89","author":"N Lazarov","year":"1990","unstructured":"Lazarov N, Chouchkov C (1990) Localization of somatostatin-like immunoreactive fibres in the trigeminal principal sensory nucleus of the cat. Acta Histochem 89:91\u201397. https:\/\/doi.org\/10.1016\/S0065-1281(11)80323-5","journal-title":"Acta Histochem"},{"key":"1717_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0301-0082(01)00021-1","volume":"66","author":"NE Lazarov","year":"2002","unstructured":"Lazarov NE (2002) Comparative analysis of the chemical neuroanatomy of the mammalian trigeminal ganglion and mesencephalic trigeminal nucleus. Prog Neurobiol 66:19\u201359","journal-title":"Prog Neurobiol"},{"key":"1717_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s10194-019-0984-1","volume":"20","author":"J Worm","year":"2019","unstructured":"Worm J, Falkenberg K, Olesen J (2019) Histamine and migraine revisited: mechanisms and possible drug targets. J Headache Pain 20:30. https:\/\/doi.org\/10.1186\/s10194-019-0984-1","journal-title":"J Headache Pain"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01717-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-024-01717-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01717-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T08:02:25Z","timestamp":1705651345000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-024-01717-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1717"],"URL":"https:\/\/doi.org\/10.1186\/s10194-024-01717-2","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,19]]},"assertion":[{"value":"23 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments and procedures were carried out according to the guidelines of the Ethical Committee for Animal Care of the University of Szeged (approval ID: XIV.\/1800\/2021 and XIV.\/2368\/2023) and carried out in accordance with the Directive 2010\/63\/EU of the European Parliament.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The first author (NF) performed this work for obtaining her PhD degree at the University of Szeged. The other authors declare no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}